利沙司他 T16756

Product Introduction
Bioactivity


英文名: Risarestat

描述: Risarestat (CT-112)是一种有效的醛糖还原酶抑制剂和甲状腺激素受体 （TR） 拮抗剂，可用于治疗低血糖症。

体内活性: In a dose-dependent manner, Risarestat inhibits the accumulation of dulcitol, with the exception of the 1.0% solution, which exhibits activity comparable to the 0.25% solution[1]. Following instillation, Risarestat peaks in the corneal epithelium, stroma, endothelium, and aqueous humor within 30 minutes, gradually diminishing time-dependently over 24 hours. Risarestat remains detectable in the lens for up to 24 hours, with a peak concentration observed at 2 hours after instillation[2]. In the group treated with Risarestat, the anterior surface area of superficial cells significantly decreases from a mean value of 881 to 728 microns^2. Corneal sensitivity significantly improves from 5.36 to 1.37 g/mm^2[3]. Animals treated with Risarestat show a significant increase in the mean blink response compared to untreated galactose-fed rats, and the response does not differ significantly from controls toward the completion of the 7-month study. However, animals treated topically with Risarestat and untreated galactose-fed rats develop bilateral nuclear cataracts within 3 weeks[3].

存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (154.60 mM)


关键字: CT-112 | CT112 | Risarestat

相关产品: Turosteride | Quercetin 3-gentiobioside | Ponalrestat | Tectoridin | ALR2-IN-1 | Aldose reductase-IN-1 | Zopolrestat | Engeletin | AT-007 | Tolrestat

利沙司他 T16756信息由TargetMol中国为您提供，如您想了解更多关于利沙司他 T16756报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途